Business Wire

Highlights Recent Investor Presentation Refuting Kimmeridge’s Continued Misstatements

Board Urges Shareholders to Vote “FOR” ALL of SilverBow’s Highly Qualified Directors on the WHITE Proxy Card

HOUSTON--(BUSINESS WIRE)-- SilverBow Resources, Inc. (NYSE: SBOW) (“SilverBow” or the “Company”) today mailed a letter to shareholders in connection with the Company’s 2024 Annual Meeting of Shareholders (the “2024 Annual Meeting”). The letter will... (continue reading...)

CHICAGO--(BUSINESS WIRE)-- GE HealthCare (Nasdaq: GEHC), a leader in precision care innovation, will host an investor day on Thursday, November 21, 2024, in New York, NY. GE HealthCare’s management team will present its growth strategies, technology portfolio, and vision for its businesses via a live webcast and will be accessible at https://investor.gehealthcare.com/news-events/events. More information, including registration details, will be available as the... (continue reading...)

Rugged meets refined with Evenflo’s newest innovation

CANTON, Mass.--(BUSINESS WIRE)-- Evenflo, designer, manufacturer, and marketer of infant and children’s products, today announced the release of its Shyft™ Rideshare™ All-Terrain Performance Stroller Wagon. Evenflo’s Shyft Rideshare accommodates up to two children aged 6 months to 5 years, with each seat holding a child up to 55 lbs. (110 lbs. total). The Shyft Rideshare is engineered for... (continue reading...)

Reliable enzymatic synthesis service overcomes limitations associated with legacy technologies, allowing scientists to significantly increase the design space that can be tested with synthetic DNA

EMERYVILLE, Calif.--(BUSINESS WIRE)-- Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced that it is expanding its early access program for its complex DNA synthesis services. More customers around the world will now be able to... (continue reading...)

AUSTIN, Texas--(BUSINESS WIRE)-- Atlas Energy Solutions Inc. (NYSE: AESI) (“Atlas” or the “Company”) today reported financial and operating results for the quarter ended March 31, 2024.

First Quarter 2024 Highlights

• Total sales of $192.7 million
• Net income of $26.8 million (14% Net Income Margin)
• Adjusted EBITDA of $75.5 million (39% Adjusted EBITDA Margin) (1)
• Net cash provided by operating activities of $39.6 million
• Adjusted Free Cash... (continue reading...)